tiprankstipranks
Genmab A/S (GMAB)
NASDAQ:GMAB
US Market

Genmab (GMAB) Financial Statements

778 Followers

Genmab Financial Overview

Genmab's market cap is currently $16.87B. The company's EPS TTM is $0.05; its P/E ratio is 19.86; Genmab is scheduled to report earnings on February 17, 2026, and the estimated EPS forecast is $0.17. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 3.72Bkr 21.53Bkr 16.47Bkr 14.51Bkr 8.42B
Gross Profitkr 3.41Bkr 20.54Bkr 16.25Bkr 14.51Bkr 8.42B
Operating Incomekr 1.25Bkr 6.70Bkr 5.32Bkr 6.27Bkr 2.95B
EBITDAkr 1.32Bkr 9.70Bkr 5.95Bkr 7.35Bkr 4.18B
Net Incomekr 963.76Mkr 7.84Bkr 4.35Bkr 5.45Bkr 2.96B
Balance Sheet
Cash & Short-Term Investmentskr 1.71Bkr 21.10Bkr 28.14Bkr 22.32Bkr 19.34B
Total Assetskr 12.84Bkr 45.81Bkr 35.29Bkr 30.12Bkr 24.63B
Total Debtkr 5.43Bkr 1.03Bkr 770.00Mkr 597.00Mkr 425.00M
Net Debtkr 3.71Bkr -8.83Bkr -14.10Bkr -9.30Bkr -8.53B
Total Liabilitieskr 7.01Bkr 9.11Bkr 3.68Bkr 2.84Bkr 2.43B
Stockholders' Equitykr 5.83Bkr 36.70Bkr 31.61Bkr 27.28Bkr 22.20B
Cash Flow
Free Cash Flowkr 1.15Bkr 7.58Bkr 7.00Bkr 3.60Bkr 1.98B
Operating Cash Flowkr 1.19Bkr 7.77Bkr 7.38Bkr 3.91Bkr 2.23B
Investing Cash Flowkr -5.65Bkr -9.91Bkr -1.28Bkr -2.76Bkr -961.00M
Financing Cash Flowkr 4.79Bkr -3.92Bkr -606.00Mkr -789.00Mkr -420.00M
Currency in DKK

Genmab Earnings and Revenue History

Genmab Debt to Assets

Genmab Cash Flow

Genmab Forecast EPS vs Actual EPS